Atai Life Sciences (ATAI) News Today $1.21 -0.07 (-5.47%) (As of 10/23/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period ATAI Life Sciences (NASDAQ:ATAI) Stock, Insider Trading ActivityOctober 15, 2024 | benzinga.comatai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 15, 2024 | finance.yahoo.comCould Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says YesOctober 8, 2024 | benzinga.comATAI Life Sciences completes acquisition of IntelGenx Corp.October 6, 2024 | investing.comIntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AGOctober 2, 2024 | globenewswire.comAtai Life Sciences N.V. (9VC.DE)September 18, 2024 | sg.finance.yahoo.comBiologists find that hardship early in life can affect health and longevity—even for marmotsSeptember 17, 2024 | msn.comATAI Atai Life Sciences N.V.September 14, 2024 | seekingalpha.comatai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comBuy Rating Affirmed for ATAI Life Sciences Amid Progress in Neurology Pipeline and Potential Market OpportunitiesAugust 31, 2024 | markets.businessinsider.comAtai Life Sciences N.V. (9VC.F)August 28, 2024 | uk.finance.yahoo.comATAI Sep 2024 2.500 put (ATAI240920P00002500)August 18, 2024 | finance.yahoo.comatai Life Sciences chief scientific officer details VLS-01 trial success - ICYMIAugust 17, 2024 | proactiveinvestors.comBuy Rating Affirmed for ATAI Life Sciences with Promising Clinical Outlook and Strategic Pipeline ReprioritizationAugust 17, 2024 | markets.businessinsider.comPositive Outlook for ATAI Life Sciences Amidst Upcoming Clinical Trials and Strategic CollaborationsAugust 17, 2024 | markets.businessinsider.comLake Street Reaffirms Their Buy Rating on Achieve Life Sciences (ACHV)August 15, 2024 | markets.businessinsider.comStrong Buy Rating for ATAI Life Sciences on Promising Clinical Data and Solid FinancialsAugust 15, 2024 | markets.businessinsider.comatai Life Sciences entering catalyst-rich period with key Phase2/3 trial data aheadAugust 14, 2024 | proactiveinvestors.comPsychedelic drug contender stocks drop after FDA rejects MDMA treatmentAugust 13, 2024 | msn.comFDA Rejection of MDMA Therapy Isn’t End of Psychedelic-Drug CandidatesAugust 13, 2024 | msn.comatai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)August 13, 2024 | finance.yahoo.comatai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesAugust 13, 2024 | finance.yahoo.comatai Life Sciences advances clinical pipeline in Q2, unveils positive VLS-01 trial resultsAugust 13, 2024 | proactiveinvestors.comatai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesAugust 13, 2024 | globenewswire.comFDA's MDMA Decision A Setback, But Long-Term Outlook For Psychedelic Stocks UnchangedAugust 12, 2024 | seekingalpha.comatai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth ConferenceAugust 7, 2024 | globenewswire.comOpenAI announces SearchGPT to rival Google - Tech & Science Daily podcastJuly 27, 2024 | ca.news.yahoo.comSergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatmentsJuly 24, 2024 | finance.yahoo.comGoogle co-founder backs biotech studying psychedelic African shrubJuly 22, 2024 | ft.com3 Dirt-Cheap Drug Developers With Blockbuster PotentialJuly 11, 2024 | investorplace.com3 Next-Gen Drug Stocks Exploring Psychedelic FrontiersJuly 8, 2024 | investorplace.com3 Psychedelic Stocks to Ride to the Moon and BeyondJuly 6, 2024 | investorplace.com3 Psychedelic Stocks to Buy on the Dip: Summer 2024July 2, 2024 | investorplace.comatai Life Sciences CEO talks successful Phase 1 trial of IV psilocin formulation – ICYMIJune 29, 2024 | proactiveinvestors.comatai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives ConferenceJune 26, 2024 | globenewswire.comatai Life Sciences optimistic as IV psilocin shows promise in treating depression in early trialJune 20, 2024 | proactiveinvestors.comatai Life Sciences Announces Update on Beckley Psytech's Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2aJune 20, 2024 | globenewswire.comatai Life Sciences poised for success with rigorous clinical trialsJune 7, 2024 | proactiveinvestors.comatai Life Sciences to Participate in the Jefferies 2024 Global Healthcare ConferenceMay 31, 2024 | globenewswire.comPsychedelic Investing For Beginners: Seize The Golden Moment!May 29, 2024 | benzinga.comATAI: Enormous Potential Upside But No Clarity YetMay 27, 2024 | seekingalpha.comatai Life Sciences Strengthens Board with Appointment of Two New Independent DirectorsMay 23, 2024 | finance.yahoo.comatai Life Sciences bolsters board with two new directorsMay 23, 2024 | proactiveinvestors.comBuy Recommendation for ATAI Life Sciences Amidst Cost-Optimization and Promising Clinical MilestonesMay 17, 2024 | markets.businessinsider.comBuy Rating Affirmed for ATAI Life Sciences Amid Promising TRD Treatment Developments and Strategic Growth PotentialMay 17, 2024 | markets.businessinsider.comatai Life Sciences poised to create value as psychedelic therapies gain traction, analysts believeMay 16, 2024 | proactiveinvestors.comatai Life Sciences boss makes way for co-founder on better first quarterMay 15, 2024 | proactiveinvestors.comatai Life Sciences Reports First Quarter 2024 Financial Results and Corporate UpdatesMay 15, 2024 | globenewswire.comHow AI Could Transform Drug Development And The Life SciencesMay 2, 2024 | forbes.comOpioid Withdrawal Syndrome Drug Market to Surge at a CAGR of 4.0% by 2034 | DelveInsightMay 1, 2024 | finance.yahoo.com Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address PANIC IN THE BANKS: 63 on the Brink of Collapse (Ad)63 banks are on the edge, drowning in $517 BILLION of unrealized losses. Interest rates are skyrocketing, and these institutions are cracking under the pressure. Click Here To Get Your FREE Guide Now! ATAI Media Mentions By Week ATAI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATAI News Sentiment▼0.000.40▲Average Medical News Sentiment ATAI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATAI Articles This Week▼02▲ATAI Articles Average Week Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DNTH News Today IMTX News Today CRON News Today ETNB News Today TNGX News Today REPL News Today ABUS News Today KRRO News Today IMNM News Today TRML News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATAI) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredGoldman Sachs’ AI warningAfter warning of last year's historic bank run, weeks in advance... Legendary stock-picker Marc Chaikin jus...Chaikin Analytics | SponsoredAmerica’s Election NightmareThanks to a new law signed by President Biden, a small group of powerful people could decide who is installed ...Banyan Hill Publishing | SponsoredIt’s delivered 859% in 2.5 months…We’ve gotten a lot of messages asking… what should we buy if Trump wins? What should we buy if Kamala wins?...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atai Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
